The relationship between PCOS and kallistatin as a diagnostic marker holds significant potential, particularly in providing support for diagnostic criteria in patients where these criteria are weak, such as in adolescents where diagnosing PCOS can be challenging. Here, SERPINA4 is linked to polycystic ovary syndrome.